Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A

Figure 1

(a) Preparation of CsA/PEG-PLGA-NPs through nanoprecipitation. DLS (b) and SEM (c) characterization of the sizes of the CsA/PEG-PLGA-NPs.

(a)

(b)

(c)